ClinicalTrials.Veeva

Menu

Change in Omega 3 Index in Healthy Adults With OmeGo or a Standard Omega-3 Oil Supplement

H

Hofseth Biocare

Status

Active, not recruiting

Conditions

Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health

Treatments

Dietary Supplement: Cod liver oil
Dietary Supplement: whole salmon oil

Study type

Interventional

Funder types

Industry

Identifiers

NCT06802068
HBC-CARDIO-2024-001-v2

Details and patient eligibility

About

Omega-3 index is used as a proxy for an adequate intake of fish unsaturated fats in the diet. However, omega-3 supplements have not consistently shown the health benefits of eating fresh fish. This study will assess the change in omega-3 index and impact on markers of cardiometabolic health with two different supplements: a whole, unprocessed salmon oil and a standard, processed, concentrated oemga-3 oil. The markers to be studies included impact on inflammation and oxidative stress, cholesterol and markers of risk of diabetes. Change in sleep metrics will also be assessed.

Full description

Omega-3 index is used as a proxy for an adequate intake of fish unsaturated fats in the diet. However, omega-3 supplements have not consistently shown the health benefits akin to eating fresh fish. This could be because contains many more fats than just EPA and DHA and these other fats have well defined health benefits such as oleic acid which is also abundant in olive oil. Alternatively this might be a result of significant processing needed to extract and concentrate the omega-3 fraction resulting in elevated levels of oxidation and free fatty acids, both of which are pro-inflammatory and would therefore impair the health benefits of omega-3. This study will assess the change in omega-3 index and impact on markers of cardiometabolic health with two different supplements: a whole, unprocessed salmon oil and a standard, processed, concentrated oemga-3 oil. The markers to be studies included impact on common drivers of inflammation and oxidative stress, blood cholesterol and markers of the risk of developing diabetes. Change in sleep metrics will also be assessed using both questionnaires and data from the hypnograms recorded by wearable device.

Enrollment

96 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy, non-pregnant adults; 40-80 years of age; stable body weight prior 3 months

Exclusion criteria

  • Fish or seafood allergies; Pregnant; already consuming fish oil supplementation; malabsorption states; malignancy in remission for less than 12 months; diabetic

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

96 participants in 2 patient groups

CARDIO salmon oil soft gel capsules
Active Comparator group
Description:
A minimally processed, whole salmon oil containing all the fatty acid fractions found in salmon
Treatment:
Dietary Supplement: whole salmon oil
Omega-3 cod liver oil soft gel capsules
Active Comparator group
Description:
A standard, processed, concentrated omega-3 supplement
Treatment:
Dietary Supplement: Cod liver oil

Trial contacts and locations

2

Loading...

Central trial contact

Crawford Currie, MBBS; Christian Bjerknes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems